Medvisus, UAB - company info and details

Company age: 11 y. 0 mo.

Update

Company overview

Company name Medvisus, UAB
Company code 304112131
Registered address Kaunas, Kranto 20-oji g. 10, LT-45293
Registration date 2015-10-20 Company age: 11 y.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 26,400 € +2% History
Profit (2025) -132 € History
Share capital 2,500 €
Number of employees 1 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 4 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity Other business support service activities n.e.c.
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Medvisus, UAB (company code 304112131) is an operational private limited liability company registered on 20 October 2015. It belongs to the sector of national private non-financial companies and is classified as a micro company under private ownership. Governance is described as CEO only, and the company capital is €2.5K. The company is based in Kaunas, at Kranto 20-oji g. 10, LT-45293, in Kauno m. municipality, Kauno apskr. county. Its registered activity is EVRK code O.82.99.00, Other business support service activities n.e.c.

Financially, the company reported revenue of €25.9K in 2024, compared with €26.6K in 2023. It recorded a net loss of €116 in 2024, close to the €115 loss in 2023, with a profit margin of -0.4% in both years. Equity remained negative, at -€1.2K in 2024 versus -€1.1K in 2023, while liabilities decreased to €707 from €1.2K. Total assets were €1.8K in 2024, down from €2.1K a year earlier. Average employment was 2 in 2023, 2024 and 2025, and so far in 2026 it has been 1 employee.

Download a detailed company report

Make confident decisions with all the information about Medvisus, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report